NAT-LENALIDOMIDE

natco pharma (canada) inc🇨🇦 Health Canada

Approval Id: 8f0cd035e55bd439
Drug Approval Canada Name: NAT-LENALIDOMIDE
Product Name: NAT-LENALIDOMIDE
Status: Marketed
Status Date: 2021-09-01
Original Market Date: 2021-09-01
Din: 02493845
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L04AX04 LENALIDOMIDE
Atc Name: l 04 ax 04
Aig Number: 0152422001
Company Name: natco pharma (canada) inc
Company Address: 2000 Argentia Road, Plaza 1, Suite 200, Mississauga, Ontario, Canada, L5N 1P7

LENALIDOMIDE

5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

8f0cd035e55bd439

Type

Standard